Nitric Acid

Nitric Acid

SCHEMBL5099641

NOCc1ccc(-n2cccn2)nc1.O=[N+]([O-])O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
NAMPT P43490 1/20 0.44
KMT2A Q03164 2/20 0.43
GRN P28799 1/20 0.43
SORT1 Q99523 1/20 0.43
CHRNA7 P36544 1/20 0.41
KDM4E B2RXH2 4/20 0.40
EGLN1 Q9GZT9 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
MERTK Q12866 1/20 0.39
IDO1 P14902 2/20 0.38
CXCR4 P61073 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1598470 0.90 LMNA (0.49) LMNANAMPTKMT2AGRNSORT1
SCHEMBL14075584 0.79 LMNA (0.53) LMNANAMPTKMT2AGRNSORT1
SCHEMBL12706294 0.76 LMNA (0.49) LMNANAMPTKMT2AGRNSORT1
SCHEMBL14494341 0.76 LMNA (0.49) LMNANAMPTKMT2AGRNSORT1
SCHEMBL30046017 0.74 LMNA (0.56) LMNANAMPTKMT2AGRNSORT1
SCHEMBL1599534 0.74 LMNA (0.56) LMNANAMPTKMT2AGRNSORT1
SCHEMBL29691288 0.74 LMNA (0.53) LMNANAMPTKMT2AGRNSORT1
SCHEMBL14638384 0.74 LMNA (0.56) LMNANAMPTKMT2AGRNSORT1
SCHEMBL14075595 0.74 LMNA (0.57) LMNANAMPTKMT2AGRNSORT1
Hydrochloric Acid SCHEMBL5012063 0.73 LMNA (0.51) LMNANAMPTKMT2AGRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080086007-A1 2-(Pyrazole-1-Yl)Pyridine Derivative SHIONOGI & CO., LTD. (JP) 2008-04-10 US disclosed
EP-1829870-A1 2-(PYRAZOL-1-YL)PYRIDINE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080086007-A1 2-(Pyrazole-1-Yl)Pyridine Derivative MRPL21, CYP1A2, PDXK LMNA 2987/4885NAMPT 2469/4885KMT2A 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.